Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licarbazepine in Bipolar Disorder
NCT00107926Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of licarbazepine in bipolar disorder (BD), sponsored by Novartis. Started Oct 2004; status: completed.
02
Drugs
licarbazepine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00107926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107926.